|
1
|
Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis.
|
Anesthesiology
|
2008
|
2.75
|
|
2
|
Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology.
|
BJU Int
|
2010
|
2.59
|
|
3
|
Side-effects of treatments for locally advanced prostate cancer.
|
BJU Int
|
2006
|
2.03
|
|
4
|
Benign prostatic hyperplasia: counting the cost of its management.
|
BJU Int
|
2010
|
1.64
|
|
5
|
The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations.
|
J Urol
|
2006
|
1.63
|
|
6
|
Optimising repeat prostate biopsy decisions and procedures.
|
BJU Int
|
2011
|
1.62
|
|
7
|
Heat shock proteins: their role in urological tumors.
|
J Urol
|
2003
|
1.56
|
|
8
|
Indicators for research performance evaluation: an overview.
|
BJU Int
|
2012
|
1.56
|
|
9
|
A catalyst for change: the European cancer Patient's Bill of Rights.
|
Oncologist
|
2014
|
1.55
|
|
10
|
A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia.
|
BJU Int
|
2004
|
1.53
|
|
11
|
Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction.
|
Am J Physiol Renal Physiol
|
2006
|
1.44
|
|
12
|
Perspectives on treatment of metastatic castration-resistant prostate cancer.
|
Oncologist
|
2013
|
1.42
|
|
13
|
Radical prostatectomy vs watchful waiting.
|
BJU Int
|
2005
|
1.41
|
|
14
|
Can lifestyle modification lower the risk of prostate cancer?
|
BJU Int
|
2010
|
1.40
|
|
15
|
Are the National Institute for Health and Clinical Excellence guidelines that promulgate active surveillance for low-risk prostate cancer justified by the available evidence?
|
BJU Int
|
2008
|
1.39
|
|
16
|
Current prospects for the chemoprevention of prostate cancer.
|
BJU Int
|
2010
|
1.39
|
|
17
|
Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma.
|
Cancer
|
2003
|
1.35
|
|
18
|
Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults.
|
Crit Rev Oncol Hematol
|
2010
|
1.34
|
|
19
|
TGF-beta1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation.
|
Am J Physiol Renal Physiol
|
2005
|
1.33
|
|
20
|
Characterisation and manipulation of docetaxel resistant prostate cancer cell lines.
|
Mol Cancer
|
2011
|
1.32
|
|
21
|
Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia.
|
Glycobiology
|
2010
|
1.20
|
|
22
|
Role of targeted therapy in the treatment of advanced prostate cancer.
|
BJU Int
|
2010
|
1.16
|
|
23
|
Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapies.
|
Clin Sci (Lond)
|
2005
|
1.16
|
|
24
|
Inhibitors of apoptosis proteins in prostate cancer cell lines.
|
Prostate
|
2002
|
1.15
|
|
25
|
Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms.
|
Prostate
|
2007
|
1.10
|
|
26
|
Electronic learning can facilitate student performance in undergraduate surgical education: a prospective observational study.
|
BMC Med Educ
|
2005
|
1.09
|
|
27
|
Biomarker research in prostate cancer--towards utility, not futility.
|
Nat Rev Urol
|
2011
|
1.07
|
|
28
|
Epidemiology of testicular cancer.
|
BJU Int
|
2009
|
1.06
|
|
29
|
Spontaneous production of monocyte chemoattractant protein-1 and interleukin-8 by the human lumbar intervertebral disc.
|
Spine (Phila Pa 1976)
|
2002
|
1.04
|
|
30
|
DNA oligonucleotide microarray technology identifies fisp-12 among other potential fibrogenic genes following murine unilateral ureteral obstruction (UUO): modulation during epithelial-mesenchymal transition.
|
Kidney Int
|
2003
|
1.04
|
|
31
|
BMI and the risk of renal cell carcinoma.
|
Curr Opin Urol
|
2011
|
1.03
|
|
32
|
Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone.
|
Blood
|
2003
|
1.00
|
|
33
|
Gender differences in the renin-angiotensin and nitric oxide systems: relevance in the normal and diseased kidney.
|
Kidney Blood Press Res
|
2007
|
0.98
|
|
34
|
2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer.
|
J Proteome Res
|
2009
|
0.98
|
|
35
|
Exploring mechanisms involved in renal tubular sensing of mechanical stretch following ureteric obstruction.
|
Am J Physiol Renal Physiol
|
2008
|
0.98
|
|
36
|
Androgen-mediated resistance to apoptosis.
|
Prostate
|
2002
|
0.97
|
|
37
|
The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkers.
|
Cancer Biol Ther
|
2009
|
0.97
|
|
38
|
Delayed graft function: a dilemma in renal transplantation.
|
BJU Int
|
2005
|
0.97
|
|
39
|
Caffeic acid phenethyl ester-induced PC-3 cell apoptosis is caspase-dependent and mediated through the loss of inhibitors of apoptosis proteins.
|
BJU Int
|
2004
|
0.96
|
|
40
|
The Reten-World survey of the management of acute urinary retention: preliminary results.
|
BJU Int
|
2008
|
0.95
|
|
41
|
Mechanical deformation induced apoptosis in human proximal renal tubular epithelial cells is caspase dependent.
|
J Urol
|
2004
|
0.95
|
|
42
|
Biomarkers in renal cell carcinoma.
|
Curr Opin Urol
|
2009
|
0.95
|
|
43
|
Mechanical stretch regulates cell survival in human bladder smooth muscle cells in vitro.
|
Am J Physiol Renal Physiol
|
2002
|
0.93
|
|
44
|
An antisense oligonucleotide to cIAP-1 sensitizes prostate cancer cells to fas and TNFalpha mediated apoptosis.
|
Prostate
|
2004
|
0.93
|
|
45
|
Epstein criteria for insignificant prostate cancer.
|
BJU Int
|
2011
|
0.93
|
|
46
|
Applying random forests to identify biomarker panels in serum 2D-DIGE data for the detection and staging of prostate cancer.
|
J Proteome Res
|
2011
|
0.91
|
|
47
|
Chemotherapy for older patients with prostate cancer.
|
BJU Int
|
2006
|
0.90
|
|
48
|
Risk stratification for benign prostatic hyperplasia (BPH) treatment.
|
BJU Int
|
2011
|
0.90
|
|
49
|
Awareness of prostate cancer among the general public: findings of an independent international survey.
|
Eur Urol
|
2003
|
0.89
|
|
50
|
The increasing incidence of mumps orchitis: a comprehensive review.
|
BJU Int
|
2010
|
0.89
|
|
51
|
Apigenin drives the production of reactive oxygen species and initiates a mitochondrial mediated cell death pathway in prostate epithelial cells.
|
Prostate
|
2005
|
0.88
|
|
52
|
Effects of heat shock and hypoxia on neonatal neutrophil lipopolysaccharide responses: altered apoptosis, Toll-like receptor-4 and CD11b expression compared with adults.
|
Biol Neonate
|
2006
|
0.87
|
|
53
|
HSP90 expression: a new predictive factor for BCG response in stage Ta-T1 grade 3 bladder tumours.
|
Eur Urol
|
2006
|
0.87
|
|
54
|
Progression of benign prostatic hyperplasia: systematic review of the placebo arms of clinical trials.
|
BJU Int
|
2008
|
0.87
|
|
55
|
The diagnosis and management of complex renal cysts.
|
Curr Opin Urol
|
2010
|
0.87
|
|
56
|
Transforming growth factor-beta promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling.
|
Ann Surg
|
2005
|
0.87
|
|
57
|
Increased E-cadherin expression in the ligated kidney following unilateral ureteric obstruction.
|
Kidney Int
|
2008
|
0.85
|
|
58
|
The pathology of bladder cancer: An update on selected issues.
|
BJU Int
|
2006
|
0.84
|
|
59
|
Effects of titanocene dichloride derivatives on prostate cancer cells, specifically DNA damage-induced apoptosis.
|
Prostate
|
2011
|
0.84
|
|
60
|
Effects of the dual 5 alpha-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell lines.
|
Cancer
|
2006
|
0.84
|
|
61
|
The medical management of prostate cancer: a multidisciplinary team approach.
|
BJU Int
|
2006
|
0.84
|
|
62
|
The role of secreted frizzled-related protein 2 expression in prostate cancer.
|
Histopathology
|
2011
|
0.83
|
|
63
|
Targeting apoptosis in prostate cancer: focus on caspases and inhibitors of apoptosis proteins.
|
BJU Int
|
2005
|
0.83
|
|
64
|
The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia.
|
BJU Int
|
2004
|
0.83
|
|
65
|
What is the role of inflammation in the pathogenesis of prostate cancer?
|
BJU Int
|
2007
|
0.82
|
|
66
|
Heat shock-induced protection of renal proximal tubular epithelial cells from cold storage and rewarming injury.
|
J Am Soc Nephrol
|
2006
|
0.82
|
|
67
|
Gene expression profile of inflammatory neutrophils: alterations in the inhibitors of apoptosis proteins during spontaneous and delayed apoptosis.
|
Shock
|
2004
|
0.82
|
|
68
|
Urinary markers for prostate cancer.
|
BJU Int
|
2006
|
0.82
|
|
69
|
Abarelix and other gonadotrophin-releasing hormone antagonists in prostate cancer.
|
BJU Int
|
2009
|
0.82
|
|
70
|
Labor induces a maternal inflammatory response syndrome.
|
Am J Obstet Gynecol
|
2004
|
0.82
|
|
71
|
The application of nanotechnology for the treatment of metastatic prostate cancer.
|
BJU Int
|
2009
|
0.82
|
|
72
|
Urinary insulin-like growth factor 2 identifies the presence of urothelial carcinoma of the bladder.
|
BJU Int
|
2008
|
0.82
|
|
73
|
Recurrence of urothelial carcinoma of the bladder: a role for insulin-like growth factor-II loss of imprinting and cytoplasmic E-cadherin immunolocalization.
|
Clin Cancer Res
|
2008
|
0.81
|
|
74
|
Increased adhesion molecule expression in serosal fibroblasts isolated from patients with inflammatory bowel disease is secondary to inflammation.
|
Ann Surg
|
2002
|
0.81
|
|
75
|
Labor promotes neonatal neutrophil survival and lipopolysaccharide responsiveness.
|
Pediatr Res
|
2004
|
0.81
|
|
76
|
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
|
Pediatr Res
|
2005
|
0.81
|
|
77
|
Cytoprotective effects of nitrates in a cellular model of hydronephrosis.
|
Kidney Int
|
2002
|
0.80
|
|
78
|
Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4 + 3 as high or intermediate grade.
|
BJU Int
|
2009
|
0.80
|
|
79
|
Critical involvement of stress-activated mitogen-activated protein kinases in the regulation of intracellular adhesion molecule-1 in serosal fibroblasts isolated from patients with Crohn's disease.
|
J Am Coll Surg
|
2004
|
0.80
|
|
80
|
Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3).
|
BJU Int
|
2009
|
0.80
|
|
81
|
Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC).
|
BJU Int
|
2012
|
0.80
|
|
82
|
Hypoxia increases normal prostate epithelial cell resistance to receptor-mediated apoptosis via AKT activation.
|
Int J Cancer
|
2009
|
0.80
|
|
83
|
The single insult of hypoxic preconditioning induces an antiapoptotic response in human proximal tubular cells, in vitro, across cold storage.
|
BJU Int
|
2008
|
0.80
|
|
84
|
Urinary tract involvement by colorectal cancer.
|
Dis Colon Rectum
|
2003
|
0.79
|
|
85
|
Phytoestrogens derived from Belamcanda chinensis have an antiproliferative effect on prostate cancer cells in vitro.
|
J Urol
|
2004
|
0.79
|
|
86
|
An evidence-based approach to understanding the pharmacological class effect in the management of prostatic diseases.
|
BJU Int
|
2005
|
0.78
|
|
87
|
Alterations in the expression of inhibitors of apoptosis during differentiation of prostate epithelial cells.
|
BJU Int
|
2007
|
0.78
|
|
88
|
Endothelin in unilateral ureteral obstruction: vascular and cellular effects.
|
J Urol
|
2003
|
0.78
|
|
89
|
Aspirin preserves neutrophil apoptosis after cardiopulmonary bypass.
|
Shock
|
2004
|
0.78
|
|
90
|
Pressure effects on cellular systems: is there a link with benign prostatic hyperplasia?
|
Urology
|
2004
|
0.77
|
|
91
|
The importance of obtaining truly consensual informed consent.
|
BJU Int
|
2012
|
0.77
|
|
92
|
Heat shock proteins in the genitourinary system.
|
Curr Urol Rep
|
2003
|
0.77
|
|
93
|
The identification and internal validation of a preoperative serum biomarker panel to determine extracapsular extension in patients with prostate cancer.
|
Prostate
|
2012
|
0.77
|
|
94
|
Induction of nitric oxide synthase is a key determinant of progression to pulmonary injury in experimental pancreatitis.
|
Surg Infect (Larchmt)
|
2006
|
0.77
|
|
95
|
Can preoperative modelling of individual neutrophil adhesion responses predict renal morbidity?
|
Eur J Cardiothorac Surg
|
2007
|
0.77
|
|
96
|
Screening for prostate cancer: the way ahead.
|
BJU Int
|
2010
|
0.77
|
|
97
|
Effects of cyclic stretch on prostatic cells in culture.
|
J Urol
|
2002
|
0.76
|
|
98
|
PCA: prostate cancer, patient-centred approach or both?
|
BJU Int
|
2012
|
0.76
|
|
99
|
Neonatal encephalopathy is associated with altered perinatal systemic neutrophil apoptosis.
|
Am J Perinatol
|
2007
|
0.76
|
|
100
|
Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
|
BJU Int
|
2009
|
0.76
|
|
101
|
How should we advise patients about the chemoprevention of prostate cancer?
|
BJU Int
|
2005
|
0.76
|
|
102
|
Medical treatment of benign prostatic hyperplasia.
|
Postgrad Med J
|
2007
|
0.75
|
|
103
|
Prostate-specific antigen kinetics and the diagnosis and management of prostate cancer.
|
BJU Int
|
2006
|
0.75
|
|
104
|
In reply.
|
Oncologist
|
2014
|
0.75
|
|
105
|
Epidemiological studies from Europe.
|
BJU Int
|
2008
|
0.75
|
|
106
|
T1 G3 bladder cancer.
|
BJU Int
|
2008
|
0.75
|
|
107
|
Another virtual issue available online.
|
BJU Int
|
2012
|
0.75
|
|
108
|
Rising to the challenge.
|
BJU Int
|
2012
|
0.75
|
|
109
|
Minimally invasive treatment of male lower urinary tract symptoms.
|
Urol Clin North Am
|
2008
|
0.75
|
|
110
|
BUF in Sicily.
|
BJU Int
|
2008
|
0.75
|
|
111
|
East meets west in urology.
|
BJU Int
|
2012
|
0.75
|
|
112
|
BJU International. Editor's Comment.
|
BJU Int
|
2009
|
0.75
|
|
113
|
Oral tranexamic acid as a novel treatment option for persistent haematuria in patients with sickle cell disease.
|
Ann Hematol
|
2010
|
0.75
|
|
114
|
BJUI editor's comment.
|
BJU Int
|
2012
|
0.75
|
|
115
|
Getting men to talk about their health.
|
BJU Int
|
2011
|
0.75
|
|
116
|
How to avoid the 'seven deadly sins of surgery'.
|
BJU Int
|
2011
|
0.75
|
|
117
|
Twittering urology away.
|
BJU Int
|
2011
|
0.75
|
|
118
|
The role of ethical publishing in promoting the evidence-based practice of urology.
|
World J Urol
|
2011
|
0.75
|
|
119
|
Prostate cancer treatment: the times they are a' changin'.
|
BJU Int
|
2012
|
0.75
|
|
120
|
Fasting status as a consideration for human serum collection and preparation prior to depletion and analysis.
|
Electrophoresis
|
2008
|
0.75
|
|
121
|
Handling the distal ureter during open nephroureterectomy: principles and techniques.
|
BJU Int
|
2005
|
0.75
|
|
122
|
FingerTip Urology: illustrations for patient dialogue at the click of your cursor.
|
BJU Int
|
2008
|
0.75
|
|
123
|
Resistance to caspase-dependent, hypoxia-induced apoptosis is not hypoxia-inducible factor-1 alpha mediated in prostate carcinoma cells.
|
Cancer
|
2005
|
0.75
|
|
124
|
September virtual issue now available.
|
BJU Int
|
2012
|
0.75
|
|
125
|
Improved survival prospects for patients with castration-resistant prostate cancer.
|
BJU Int
|
2011
|
0.75
|
|
126
|
The trouble with men.
|
BJU Int
|
2012
|
0.75
|
|
127
|
The emerging fields of laparoendoscopic single-site surgery (less) and natural orifice transluminal endoscopic surgery (notes).
|
BJU Int
|
2010
|
0.75
|
|
128
|
Getting to a better "place": helping patients counter obesity by achieving enduring lifestyle change.
|
BJU Int
|
2011
|
0.75
|
|
129
|
The evidence basis of urology: in pursuit of 'the right stuff'.
|
BJU Int
|
2008
|
0.75
|
|
130
|
How the new BJU International website benefits prospective authors.
|
BJU Int
|
2008
|
0.75
|
|
131
|
An interview with John M. Fitzpatrick. Interviewed by Roger Kirby.
|
BJU Int
|
2012
|
0.75
|
|
132
|
Change and innovation.
|
BJU Int
|
2011
|
0.75
|
|
133
|
A gender comparison of postobstructive injury in the rat kidney.
|
Kidney Blood Press Res
|
2010
|
0.75
|
|
134
|
Prevention and management of haematomata after minimally invasive radical prostatectomy.
|
BJU Int
|
2011
|
0.75
|
|
135
|
Bladder cancer today.
|
BJU Int
|
2008
|
0.75
|
|
136
|
BJU International. Editor's comment.
|
BJU Int
|
2008
|
0.75
|